Hepatotoxic and Neurotoxic Potential of Iron Oxide Nanoparticles in Wistar Rats: a Biochemical and Ultrastructural Study

Author(s):  
Mostafa Mabrouk ◽  
Ghadha Ibrahim Fouad ◽  
Sara A. M. El-Sayed ◽  
Maha Z. Rizk ◽  
Hanan H. Beherei
2018 ◽  
Vol 9 (3) ◽  
pp. 209-216 ◽  
Author(s):  
Fatemeh Saeidienik ◽  
Mohammad Reza Shahraki ◽  
Hamed Fanaei ◽  
Fereshteh Badini ◽  
◽  
...  

2020 ◽  
Vol 77 ◽  
pp. 80-93 ◽  
Author(s):  
Heba M. Fahmy ◽  
Esraa M. Aly ◽  
Faten F. Mohamed ◽  
Neveen A. Noor ◽  
Anwar A. Elsayed

2021 ◽  
pp. 074823372110586
Author(s):  
Gajraj S Verma ◽  
Naresh K Nirmal ◽  
Deepika Gunpal ◽  
Hemant Gupta ◽  
Monika Yadav ◽  
...  

Nanoparticles of iron oxide, with diameters beteween 1 to 100 nm, have notable implications for human health and well being. In the current study, we have investigated the effects of iron oxide nanoparticles (IONP) exposure on general physiology and health of adult Wistar rats. IONP used in the study had spherical shape and average size in the range of 15–20 nm. A total of eight groups of rats were repeatedly injected with 0 (control), 20, 40, and 80 mg IONP per kg body weight intraperitoneally under two different exposure schemes (sub-acute and sub-chronic). IONP exposure caused significant changes in lungs, liver, and kidney indices in both exposure schemes. Sub-acute exposure did not affect body weight gain in treated rats, but longer duration exposure was responsible for significant reduction in body weight. Mesenteries, visceral fatty tissues, and visceral peritoneal membranes demonstrated apparent accumulations of IONP in a dose and time-dependent manner. Hematological analysis showed that total RBC count, hemoglobin content, hematocrit, mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC) and mean platelet volume (MPV) were not affected by IONP exposure. Total lymphocyte count, however, was elevated in low- and mid-dose treated rats, but not in high-dose group. Serum lactate dehydrogenase (LDH) increased significantly in rats treated with mid and high doses as compared to control. Serum creatinine and blood urea nitrogen levels were also significantly altered in treated rats. Histological study found significant hepatic damage and mild spleen toxicity. Our report suggests that IONP exhibit significant toxicity in rats.


2014 ◽  
Vol 229 ◽  
pp. S197 ◽  
Author(s):  
Ruzica Rozgaj ◽  
Vilena Kasuba ◽  
Marin Mladinic ◽  
Nevenka Kopjar ◽  
Vedran Micek ◽  
...  

2012 ◽  
Vol 36 (3) ◽  
pp. 296-305 ◽  
Author(s):  
Monika Kumari ◽  
Sheik Rajak ◽  
Shailendra P. Singh ◽  
Upadhyayula S. N. Murty ◽  
Mohammed Mahboob ◽  
...  

2018 ◽  
Vol 6 (10) ◽  
Author(s):  
Hosam Zaghloul ◽  
Doaa A. Shahin ◽  
Ibrahim El- Dosoky ◽  
Mahmoud E. El-awady ◽  
Fardous F. El-Senduny ◽  
...  

Antisense oligonucleotides (ASO) represent an attractive trend as specific targeting molecules but sustain poor cellular uptake meanwhile superparamagnetic iron oxide nanoparticles (SPIONs) offer stability of ASO and improved cellular uptake. In the present work we aimed to functionalize SPIONs with ASO targeting the mRNA of Cyclin B1 which represents a potential cancer target and to explore its anticancer activity. For that purpose, four different SPIONs-ASO conjugates, S-M (1–4), were designated depending on the sequence of ASO and constructed by crosslinking carboxylated SPIONs to amino labeled ASO. The impact of S-M (1–4) on the level of Cyclin B1, cell cycle, ROS and viability of the cells were assessed by flowcytometry. The results showed that S-M3 and S-M4 reduced the level of Cyclin B1 by 35 and 36%, respectively. As a consequence to downregulation of Cyclin B1, MCF7 cells were shown to be arrested at G2/M phase (60.7%). S-M (1–4) led to the induction of ROS formation in comparison to the untreated control cells. Furthermore, S-M (1–4) resulted in an increase in dead cells compared to the untreated cells and SPIONs-treated cells. In conclusion, targeting Cyclin B1 with ASO-coated SPIONs may represent a specific biocompatible anticancer strategy.


Sign in / Sign up

Export Citation Format

Share Document